Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEmpyrean Regulatory News (EME)

Share Price Information for Empyrean (EME)

Share Price is delayed by 15 minutes
Get Live Data
0.0425    -0.0025 (-5.56%)
Bid:
0.04
Ask:
0.045
Spread: 0.005 (12.50%)
Market Cap: £2.43m
EME Live PriceLast checked at - London Stock Exchange

Intraday Empyrean Share Chart

Sugarloaf: Marathon permit update

12 Sep 2013 08:00

RNS Number : 8152N
Empyrean Energy PLC
12 September 2013
 

12 September 2013

Empyrean Energy PLC

("Empyrean" or the "Company"; Ticker: EME)

 

Sugarloaf AMI Project: Onshore Texas, USA

 

Empyrean Energy Plc, the AIM-listed condensate and gas exploration and production company focused on the Eagle Ford Shale, Texas, USA, notes that Marathon Oil Corporation (NYSE:MRO) ("Marathon"), the operator of Empyrean's interests in the Sugarloaf AMI has lodged new well permits since June 2013 that imply a 40 acre spacing between a number of the newly permitted wells. Empyrean notes that Marathon has been undertaking a study and testing to establish optimal well spacing for the future development of the field.

 

Whilst these recent permits are encouraging, Empyrean wishes to clarify Marathon's current position with respect to the permits and spacing in general as follows:

 

"Any wells at 350' foot spacing are ongoing "pilot" wells in the expanding infill density spacing program. Marathon continues to widely test 40 ac groups of wells as part of the process to test the relative performance and economic merits of higher infill density. Until Dec of 2013, Marathon does not anticipate any public declaration of commercial spacing in the Sugarloaf AMI area."

 

Commenting today, Empyrean CEO Tom Kelly said, "The JV continues to test spacing below 80 ac across the AMI area to validate well performance with expectations of more detailed development plans in late 2013 becoming available."

 

Further Information

 

 

The information contained in this announcement was completed and reviewed by the Technical Director of Empyrean Energy Plc, Mr Frank Brophy BSc (Hons) who has over 40 years experience as a petroleum geologist.

 

**ENDS**

 

For further information please visit www.empyreanenergy.com or contact the following:

 

Tom Kelly

Empyrean Energy plc

Tel: +618 9480 0111

Anita Ghanekar

Shore Capital Stockbrokers Limited

Tel: +44 (0) 207 408 4090

Edward Mansfield

Shore Capital Stockbrokers Limited

Tel: +44 (0) 207 408 4050

Hugo de Salis

St Brides Media & Finance Ltd

Tel: +44 (0) 20 7236 1177

Elisabeth Cowell

St Brides Media & Finance Ltd

Tel: +44 (0) 20 7236 1177

Lottie Brocklehurst

St Brides Media & Finance Ltd

Tel: +44 (0) 20 7236 1177

 

 

Notes to Editors:

 

Empyrean Energy Plc is an AIM listed (Ticker : EME) condensate and gas exploration and production company focused on the Eagle Ford Shale, Texas, USA. Other assets include a 10% working interest in the Riverbend Project, Texas, as well as a 57.2% interest in the Eagle Oil Pool Development Project located in the San Joaquin Basin, southern California.

 

Empyrean's portfolio includes an interest in over 91 producing wells with scaleable growth potential from further development and exploration upside.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCNKBDPABKKACD
Date   Source Headline
6th Feb 20251:49 pmRNSHolding(s) in Company
5th Feb 20252:47 pmRNSHolding(s) in Company
30th Jan 20257:00 amRNS£675,000 Placing
28th Jan 20253:39 pmRNSHolding(s) in Company
28th Jan 20257:50 amRNSLand access agreement for Wilson River 1 secured
23rd Jan 20257:00 amRNSParticipation option in the Wilson River prospect
6th Jan 20257:00 amRNSHolding(s) in Company
18th Dec 20247:00 amRNSInterim Results
4th Dec 20247:00 amRNSHolding(s) in Company
2nd Dec 202412:14 pmRNSResults of General Meeting
13th Nov 20247:00 amRNSPosting of Circular
12th Nov 20249:00 amRNSChange of Registered Office Address
11th Nov 202410:15 amRNSResults of Retail Offer
6th Nov 20247:22 amRNSRetail Offer
6th Nov 20247:00 amRNSProposed Fundraise and Capital Reorganisation
28th Oct 202412:11 pmRNSResults of General Meeting
8th Oct 20249:19 amRNSHolding(s) in Company
2nd Oct 202411:05 amRNSPosting of Annual Report and Notice of GM
1st Oct 20247:00 amRNSFinal Results
30th Sep 202410:48 amRNSResult of AGM
19th Sep 20244:14 pmRNSHolding(s) in Company
4th Sep 20241:36 pmRNSPosting of Notice of Annual General Meeting
2nd Sep 20247:00 amRNSGas Sale Agreement Signed with Sembcorp
22nd Aug 20249:02 amRNSBoard Restructure
26th Jul 20248:30 amRNSIssue of Salary Sacrifice Shares
24th Jun 20247:00 amRNSMako Binding Gas Sale Agreement Signed with PGN
13th Jun 20247:00 amRNSBlock 29/11 China update
5th Apr 20247:00 amRNSDirector/PDMR Shareholding
28th Mar 20247:57 amRNSMako Gas Sale Key Terms Signed with PGN
23rd Feb 20247:39 amRNSMinisterial Approval of Mako Gas Price
13th Feb 20247:00 amRNSEmpyrean completes £700,000 Placing
31st Jan 20247:00 amRNSDuyung PSC Update
18th Dec 202311:34 amRNSInterim Results
20th Nov 20232:40 pmRNSChange of Nominated Adviser
27th Sep 202312:58 pmRNSResult of AGM
15th Sep 20237:00 amRNSIssue of Salary Sacrifice Shares
12th Sep 20237:13 amRNSKey Terms Agreed for Long-Term Gas Sales Agreement
4th Sep 20237:00 amRNSPosting of Annual Report and Notice of AGM
1st Sep 202312:30 pmRNSFinal Results
30th May 20237:36 amRNSCapital raising, Debt Restructure & Company Update
2nd May 20237:00 amRNSMako gas field - Update
4th Jan 20234:40 pmRNSSecond Price Monitoring Extn
4th Jan 20234:35 pmRNSPrice Monitoring Extension
3rd Jan 20234:40 pmRNSSecond Price Monitoring Extn
3rd Jan 20234:35 pmRNSPrice Monitoring Extension
20th Dec 20227:00 amRNSInterim Results
23rd Nov 20224:36 pmRNSPrice Monitoring Extension
8th Nov 20227:00 amRNSMako Gas - Approval of Updated Plan of Development
19th Oct 20221:19 pmRNSResults of General Meeting
27th Sep 202212:54 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.